PRESS RELEASE published on 06/21/2024 at 09:30, 2 years 1 month ago Press Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi’s Executive Committee Audrey Duval Derveloy appointed Global Head of Corporate Affairs at Sanofi, joining Executive Committee. Responsible for stakeholder engagement and CSR strategy globally Executive Committee Sanofi Audrey Duval Derveloy Corporate Affairs Global Head
BRIEF published on 06/21/2024 at 07:05, 2 years 1 month ago Sanofi strengthens its leadership in the treatment of hemophilia Sanofi Fitusiran ISTH Haemophilia ALTUVIIO
PRESS RELEASE published on 06/21/2024 at 07:00, 2 years 1 month ago Press Release: ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and fitusiran Sanofi presents new data on ALTUVIIIO and fitusiran at ISTH Congress, showcasing potential first- and best-in-class treatments for hemophilia. Fitusiran NDA under FDA review with PDUFA date of March 28, 2025 Sanofi ALTUVIIIO Fitusiran Hemophilia ISTH Congress
BRIEF published on 06/12/2024 at 20:24, 2 years 1 month ago Sanofi: Information on voting rights and shares - May 2024 Voting Rights Investors Actions Sanofi May 2024
PRESS RELEASE published on 06/12/2024 at 20:19, 2 years 1 month ago Sanofi: Information concerning the total number of voting rights and shares – May 2024 Sanofi discloses total number of voting rights and shares as per French commercial code and stock market authority regulations. Details available on Sanofi's website Voting Rights French Commercial Code Shares Sanofi Stock Market Authority
BRIEF published on 06/03/2024 at 22:20, 2 years 1 month ago Phase III study: Sarclisa improves progression-free survival of patients with multiple myeloma Multiple Myeloma Sarclisa ASCO Phase III Study Progression-free Survival
PRESS RELEASE published on 06/03/2024 at 22:15, 2 years 1 month ago Press Release: ASCO: Sarclisa is first anti-CD38 to significantly improve progression-free survival in combination with VRd for newly diagnosed transplant-ineligible multiple myeloma in phase 3 Sarclisa in combo with VRd significantly enhances progression-free survival in newly diagnosed transplant-ineligible multiple myeloma in phase 3 study at ASCO. Full data published in NEJM Multiple Myeloma Phase 3 Sarclisa Progression-free Survival VRd
BRIEF published on 05/31/2024 at 12:05, 2 years 2 months ago Sanofi Launches 2024 Global Employee Stock Purchase Plan Financial Investment Sanofi Employee Stock Purchase Plan Action 2024 Global Participation
PRESS RELEASE published on 05/31/2024 at 12:00, 2 years 2 months ago Press Release: Sanofi launches 2024 global Employee Stock Purchase Plan Sanofi launches 2024 global Employee Stock Purchase Plan, Action 2024, offering discounted shares to 80,000 employees in 56 countries. CEO Paul Hudson affirms commitment to employee participation and company growth Company Growth Sanofi Employee Stock Purchase Plan Action 2024 Employee Shareholders
BRIEF published on 05/31/2024 at 07:10, 2 years 2 months ago CHMP recommends approval of Dupixent in the EU for the treatment of patients with COPD Sanofi COPD Dupixent CHMP Supply
Published on 08/01/2026 at 01:20, 2 days ago Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 2 days ago Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 2 days 1 hour ago Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 07/31/2026 at 23:20, 2 days 2 hours ago Pentagon I Capital Corp. Announces Conditional Acceptance of Qualifying Transaction with Prospectiva Resources Ltd.
Published on 08/03/2026 at 00:05, 1 hour 59 minutes ago Publication of the result of the voluntary public tender offer for all Addiko shares
Published on 08/02/2026 at 08:15, 17 hours 49 minutes ago Holcim signs agreement to divest its business in the Philippines
Published on 08/01/2026 at 16:35, 1 day 9 hours ago HIZENERGY Enters Global Top Tier with BloombergNEF Tier 1 Listing
Published on 07/31/2026 at 19:55, 2 days 6 hours ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA Reaches Agreement with Financing Partners on Extension of Standstill Agreement and Continuation of Restructuring Process
Published on 07/31/2026 at 19:05, 2 days 6 hours ago Eurobattery Minerals presents the Q2 report for 2026 as the Company accelerates the development of the San Juan tungsten project
Published on 07/31/2026 at 21:00, 2 days 5 hours ago Carrefour completes the sale of its minority stake in CarrefourSA in Turkey to Yeni Mağazacılık A.Ş., operator of the A101 retail chain and controlled by the Aydın Group
Published on 07/31/2026 at 19:13, 2 days 6 hours ago Covivio - Information on Treasury shares transactions between July 29th, 2026 and July 31st, 2026
Published on 07/31/2026 at 18:30, 2 days 7 hours ago Covivio Hotels - 2026 Half-year financial report